Skip to main content
Full access
Clinical Synthesis
Published Online: 1 January 2014

Key Factors in Diagnosing and Treating Adolescent Eating Disorders

Abstract

There has been considerable progress in the clinical management of eating disorders in adolescence in the past decade. DSM-5 has been revised to be more sensitive to the clinical importance of the early presentations of eating disorders, which should lead to earlier identification, more accurate diagnoses, and more rapid intervention for this younger population. In addition, new systematic studies of treatments now support the use of a particular form of family therapy (FBT) for adolescents with anorexia nervosa. Preliminary data support the use of other forms of family therapy and in some instances individual therapy for this disorder in teenagers. The role of hospitalization has been examined and data suggest that for adolescents with anorexia nervosa, hospitalization for weight restoration is not superior to outpatient treatments in most instances. However, where access to quality outpatient care is lacking, and in some instances even where excellent outpatient care is applied, inpatient care may be necessary. There is no doubt that some patients need and benefit from inpatient weight restoration programs, but we do not yet know how best to identify for whom this costly treatment is needed. For adolescents with bulimia nervosa and binge eating disorder, systematic investigations of psychosocial treatments are few and there is no substantial evidence base supporting any specific treatment. However, preliminary studies support the clinical effectiveness of FBT, Cognitive Behavioral Therapy, Dialectical Behavior Therapy, and Interpersonal Psychotherapy for these disorders, but systematic studies are lacking. Psychopharmacologic interventions have not been proven to be systematically useful in adolescent eating disorders, but their clinical use may be indicated in refractory cases and when there is significant psychiatric comorbidity. Future advances in clinical diagnosis and treatment of eating disorders in adolescents will likely result from ongoing and novel studies of the neural underpinnings and psychological cognitive processes associated with these disorders.

Clinical Context

Eating disordered thoughts and behaviors onset primarily in the adolescent years (1, 2). Anorexia Nervosa (AN) has a peak incidence rate at approximately 15 years of age and it is rare for onset to occur after the age of 25 years (3, 4). Although the incidence of Bulimia Nervosa (BN) peaks in the late teenage years, disordered eating, including binge eating and purging at subthreshold rates, begins in the middle teenage years (1, 5, 6). Binge eating often begins in childhood and adolescence (79), but Binge Eating Disorder (BED) is not typically diagnosed until early and middle adulthood (10, 11). These epidemiology data relating age and eating disordered behavior underscore the importance of understanding the presentation and treatment of eating disorders in youth. Nonetheless, until relatively recently, the need to focus on this younger age group had not been a priority.
Despite the description of AN in the medical literature for several hundred years (12, 13), it was not until 1987 that the first randomized clinical trial (RCT) examining treatments for adolescents with AN was published (14). There was not a subsequent completed RCT focused on treatment for adolescents with AN published for another decade (15). While there are a number of effective treatments for adults with BN based on a relatively large evidential base (16, 17), for adolescent BN, there remain only two RCTs examining treatments, both published in 2007 (18, 19). As for BED, there are limited evaluating treatments for youth (2023) despite a comparatively robust number of studies in adults with this disorder (2430).

Diagnostic Issues

One reason for the lack of emphasis on youth with disordered eating is related to the diagnostic criteria of former iterations of the Diagnostic and Statistical Manual of Mental Disorders (DSM). The criteria used for diagnostic categorization were based primarily on adult phenotypic symptom presentation without regard for symptom evolution or developmental variation (31). This led to delays in the diagnosis of children and adolescents with eating disorders (32). Reasons for failure to meet DSM diagnostic criteria included inaccurate strategies for assessing weight (3335), differences in ability to verbalize internal states and motivation (36), inappropriate behavioral threshold or duration of behaviors (37), and the failure to utilize parental report in the evaluation of younger patients (3739). Some of these deficiencies are corrected in DSM-5, especially for adolescent AN. In addition to these changes, the authors of DSM-5 have added a new diagnosis, Avoidant Restrictive Food Intake Disorder (ARFID) that encompasses a range of eating problems not associated with disordered thinking about appearance and weight (40). Taken together, these changes will likely reduce the number of patients who previously were diagnosed in the vague Eating Disorder Not Otherwise Specified (EDNOS) group and (41, 42) likely make it easier for clinicians to more accurately diagnose children and adolescents with eating disorders. Nonetheless, the ability to understand the interface of eating disorder symptoms and developmental variation in the context of cognitive, social, and emotional development is a refined skill requiring rather extensive training and experience.
In addition to the diagnostic challenges in youth with eating disorders, as suggested above, our understanding of effective treatments for younger patients is limited by the state of current research in the field. There are 11 randomized controlled trials (RCTs) that included a total of approximately 1000 adolescent participants 19 years of age or younger published for AN (14, 15, 4350). In contrast to studies of BN for adults where there are many studies available (16, 17, 51), there are only two published RCTs examining treatment for adolescents with BN. These studies include 165 adolescent participants and examined FBT for BN, CBT (self-help), and individual therapy (supportive) (18, 19). Similarly, treatment of BED in adults has received considerable attention in RCTs (10, 23, 24, 26, 29), but BED is relatively unexamined in adolescents (20, 21, 52). As noted, ARFID is a new diagnosis in DSM-5, but there are no empirical studies to guide treatment for this disorder. Thus, the database is limited and conclusions about the most effective treatment approaches are tentative.

Psychosocial Treatments For Anorexia Nervosa In Adolescents

The best evidence-based treatment for adolescents with AN is a specific form of family therapy, called Family-Based Treatment (FBT). The approach was developed at the Institute of Psychiatry at the Maudsley Hospital in London and manualized at Stanford University and The University of Chicago (5355). In contrast to historical approaches, which typically excluded parents by hospitalizing patients (13) or focusing individual therapy on autonomy struggles and self-efficacy (56, 57), FBT promotes parental management of eating disordered behaviors in their children early in treatment until the child is better able to manage his or her behaviors in at an age-appropriate level of independence. Of the 11 published studies referenced above for adolescent AN, 7 of them examined FBT (14, 15, 43, 44, 48, 58). Although the earliest studies suffered from a range of methodological limitations, taken together the results of these support the view that FBT is an effective approach for the outpatient management of adolescents with short duration AN (51, 59). Further, the results suggest that compared with other approaches so far studied, FBT works quickly (60), reduces the need for hospitalization (44, 61), produces higher rates of recovery (14, 48), and lowers costs (62). Despite these encouraging findings, FBT has not been rigorously compared with many other potentially effective treatments for adolescents with AN, including cognitive behavior therapy (CBT) (66), interpersonal psychotherapy (64), or dialectical behavioral therapy (65), which are all potentially useful approaches.
In addition to FBT, other family approaches have been of recent research interest. One study from France compared treatment as usual (TAU) to TAU plus a family therapy targeting family psychological process (50). In contrast to FBT, which views the family as a potentially effective resource to help their children with AN, this type of family therapy does not promote familial management of the symptoms of AN, but instead aims to address family conflicts and communication style. The study included 60 randomized female participants (30 per group) between 13 and 19 years of age. There were no statistically significant differences in outcomes between the two randomized groups using an intent-to-treat analysis, but in a completer sample, the group that received TAU plus family therapy gained more weight and had higher rates of menstrual return. The study provides limited, but systematic support for the potential utility of a type of family therapy targeting family processes rather than symptom management. Another recent study of 164 adolescents with AN directly compared FBT to a manualized form of systemic family therapy (SFT) (66) in a multisite randomized protocol.
Moderators of outcome are of interest because any single treatment is likely to not be effective for all patients (67). To identify moderators of treatment effects, it is necessary to compare outcomes based on baseline characteristics of participants randomized to different treatments (68). There are few studies of moderators of treatment effect in adolescents with AN. However, one study examined whether there were different patient groups that needed more or less FBT based on their baseline characteristics (44). Participants in this study who came from single parent or reconstituted families (remarried) did better if they received more therapy. Also, those participants with higher levels of obsessive-compulsive features related specifically to eating did better with more treatment. Another study that compared individual therapy to family therapy found that three markers of severity (level of eating related psychopathology, level of obsessive compulsive thinking about eating, and purging behaviors) moderated outcome with patients who received FBT doing better (69). The authors concluded that those adolescents who were most severely ill needed the help of the parents to recover, while those with milder symptoms could be helped just as well in individual therapy.
While most studies of adolescent AN have focused on outpatient treatment, one important study examined the potential benefits of a highly specialized psychiatric inpatient treatment program for this age group in a large RCT. Hospitalization for the acute physiological management of the consequences of severe malnutrition is necessary (70), but there is an ongoing debate about whether inpatient weight restoration is needed (46, 71). Early studies found conflicting evidence, but in the first RCT to examine this question for adolescents with AN, Gower and colleagues randomized 167 adolescents (aged 12–18 years) with AN to a specialized eating disorder inpatient treatment program, outpatient CBT, or TAU at the local mental health program (47). Overall 33% of the participants had a good clinical outcome while 27% still met criteria for full syndrome AN at follow-up. Those participants who received the highly specialized long-term inpatient treatment (about 16 weeks) had no better outcomes than those who received weekly outpatient therapy. This led the authors to conclude that there was no advantage to utilizing a specialized inpatient eating disorder treatment program as an initial treatment for adolescents with AN. Further, either of the other outpatient approaches was superior in terms of cost-effectiveness (72). It is important to note that this study did not conclude that hospitalization for weight restoration is not effective or not needed, but suggests on average, that it is not likely to lead to superior outcomes. There is no doubt that some patients need and benefit from inpatient weight restoration programs, but we do not yet know how best to identify for whom this costly treatment is needed.

Psychosocial Treatments For Bulimia And Binge Eating Disorder In Adolescents

Turning to BN in adolescents, the two published studies find differing results. In one study, FBT was compared with individual supportive therapy. The study employed a randomized design that included 80 adolescents (mean age 16 years) with BN or clinically significant binge eating and purging (19). At the end of treatment and at the one year follow-up, FBT was statistically superior to this comparison treatment. This study also examined moderators and found that adolescents with less severe eating-related psychopathology before starting treatment did better in FBT (73). This finding contrasts with the finding above related to adolescents with AN for whom FBT was superior when they showed evidence of greatest symptomatic severity (69). The second published RCT randomized 85 adolescents and young adults (mean age about 18 years) with BN and/or binge eating to either family therapy or a self-help version of CBT (18). There were no differences in outcome between the groups. Overall about 35% no longer reported binge eating or purging. Based on these two studies, there is insufficient data to support recommending a specific therapy for adolescent BN at this time. Both family and cognitive behavioral interventions appear helpful for about a third of treatment-seeking adolescents with this disorder.
It is also important that treatments that are found to be effective in RCTs and in specialized clinical settings be studied in more generalized clinical settings. Research into dissemination and implementation of treatments for eating disorders is in the early stages. The results examining the viability of FBT for dissemination and implementation in diverse settings are promising, however. FBT has been implemented in diverse academic medical centers in the U.S. (74) as well as in treatment programs in the U.K., Brazil, Australia, New Zealand, and Canada (61, 7477). In addition, two broader implementation efforts, both in Australia, suggest that the benefits of FBT led to systematic decreases in hospitalization use. At a children’s hospital in Sydney readmission rates of adolescents with AN dropped by 50% as FBT was implemented (64). Similarly, at another children’s hospital in Melbourne, hospitalization admissions decreased by 56% and readmissions decreased by 75%. There was also a 51% decrease in overall hospital days (78). However, these improvements were accomplished only by overcoming some significant challenges, particularly because initially therapists expressed concerns about the FBT model and its impact on professional roles. Specifically, the more circumscribed role of registered dieticians and medical providers in FBT was initially an uncomfortable fit for many therapists. These findings echo similar reports from a qualitative report from Canada examining therapist attitudes toward FBT (79). While these preliminary studies are promising, most aspects of dissemination and implementation remain unexplored, including barriers to adopting evidence based treatments other than FBT as well as identifying effective strategies for efficient training and also skills maintenance strategies.

Medication Treatments For Adolescents with Eating Disorders

Medication treatment for eating disorders has been the subject of a number of studies in adults. No medications are known to be systematically useful for AN (80, 81), while SSRIs and other antidepressants can be helpful in adults with BN and BED (16). There was initial enthusiasm for the use of atypical antipsychotics for adolescents with AN (82), but the few systematic studies available do not support the systematic benefit of these medications for this disorder in this age group (83). Unfortunately, no randomized clinical trials have examined medication treatment for adolescents with BN or BED.

Future developments in treating adolescents with eating disorders

It is interesting to note that two treatments that have been used successfully in adults with a range of eating disorders—CBT and interpersonal psychotherapy (IPT)—have received little systematic study in adolescents. CBT has the most substantial database for the treatment of BN and BED, but there are only case series data available for the use of this treatment in adolescents (63, 84). However, data from these cases series suggest that CBT may be useful for adolescents with AN and BN. Similarly, only case series data are available for IPT (52), a therapy that focuses on specific interpersonal problems associated with the onset or maintenance of eating disorder symptoms. IPT has been studied in adults with BED and piloted with adolescents with BED (20, 21, 29).
Some of the most exciting future developments for eating disorder treatment in youth are likely to arise from novel findings related to the neurobiological basis of these disorders (87). It is possible that medications, psychosocial treatments, and cognitive treatments will be informed by a better understanding of the neural underpinnings of these disorders. Studies suggest underlying differences in the brain activation associated with the neurocircuitry related to cognitive inhibition (86, 87), emotion regulation (88), and reward processing (89, 90). Treatments targeting cognitive and emotional regulation processes in patients with eating disorders are being developed. Cognitive Remediation Therapy (CRT) for eating disorders aims to improve perseverative and overly detailed thinking styles associated with them through cognitive exercises (9195). The use of CRT is helpful for treating brain injury, schizophrenia, and OCD (9698). These exercises do not focus on eating or weight, but instead target general cognitive style rather than content. Only one published RCT examining CRT included adolescents (over the age of 16 years) and adults (99). The study compared CRT to CBT over two months and found that treatment dropout was lower in CRT and there were greater changes in both cognitive flexibility and detailed processing in those randomized to CRT. However, there were no differences in any eating disorder related behaviors or psychopathology between the two treatments at the end of treatment, despite these being the targets of CBT.
Dialectical Behavior Therapy (DBT) is another experimental psychosocial treatment of eating disorders and targets emotion regulation (30). The DBT model conceptualizes eating disordered behaviors as maladaptive attempts to cope with overwhelming emotions. By overcoming the challenge of difficulties in emotion regulation, general self-regulatory behaviors (100) broadly defined will also improve (101, 102). In this sense, DBT attempts to help patients to modulate affect to prevent an eating disordered behavior (e.g., a binge episode) rather than targeting behavioral and cognitive strategies to change dietary restraint (as in CBT). In the context of eating disorders in youth, DBT may be particularly helpful because self-regulatory skills are linked to frontal-lobe development during adolescence and young adulthood and coincide with highest risk period for the development of eating disorders (101, 103, 104). The results of studies in adults with BED and BN provide preliminary support for the clinical use of DBT (28, 65, 105, 106); however, systematic studies using DBT in an adolescent sample with eating disorders are not yet available.
There has been considerable progress in the clinical management of eating disorders in adolescence in the past decade. DSM-5 has been revised to be more sensitive to the clinical importance of the early presentations of eating disorders, which should lead to earlier identification, more accurate diagnoses, and more rapid intervention for this younger population. In addition, new systematic studies of treatments now support the use of a particular form of family therapy (FBT) for adolescents with AN. Some systematic data support the use of other forms of family therapy and in some instances individual therapy for this disorder in teenagers. The role of hospitalization has been examined and data suggest that for adolescents with AN, hospitalization for weight restoration is not superior to outpatient treatments in most instances. However, where access to quality outpatient care is lacking, and in some instances even where excellent outpatient care is applied, inpatient care may be necessary. It is known that some patients need and benefit from inpatient weight restoration programs, but we do not yet know how best to identify for whom this costly treatment is needed. For adolescents with BN and BED, systematic investigations of psychosocial treatments are few and there is no substantial evidence base supporting any specific treatment. However, preliminary studies support the clinical effectiveness of FBT, CBT, DBT, and IPT for these disorders, but systematic support is lacking. Similarly, psychopharmacologic interventions have not been shown in systematic studies to be useful in adolescent eating disorders, but their clinical use may be indicated in refractory cases and when there is significant psychiatric comorbidity. Future advances in clinical diagnosis and treatment of eating disorders in adolescents will likely result from ongoing and novel studies of the neural underpinnings and psychological cognitive processes associated with these disorders.

References

1.
Swanson SA, Crow SJ, Le Grange D, Swendsen J, Merikangas KR: Prevalence and correlates of eating disorders in adolescents; results from the national comorbidity survey replication adolescent supplement. Arch Gen Psychiatry 2011; 68:714–723
2.
Nicholls DE, Lynn R, Viner RM: Childhood eating disorders: British national surveillance study. Br J Psychiatry 2011; 198:295–301
3.
Hoek HW, van Hoeken D: Review of the prevalence and incidence of eating disorders. Int J Eat Disord 2003; 34:383–396
4.
Pinhas L, Morris A, Crosby RD, Katzman DK: Incidence and age-specific presentation of restrictive eating disorders in children: a Canadian Paediatric Surveillance Program study. Arch Pediatr Adolesc Med 2011; 165:895–899
5.
Hudson JI, Hiripi E, Pope HGJ Jr, Kessler RC: The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007; 61:348–358
6.
Stice E, Agras WS: Predicting onset and cessation of bulimic behaviors during adolescence. Behav Ther 1998; 29:257–276
7.
Decaluwe V, Braet C: Prevalence of binge eating in obese children and adolescents seeking weight loss treatment. Int J Obes 2003; 27:404–409
8.
Glasofer DR, Tanofsky-Kraff M, Eddy KT, Yanovski SZ, Theim KR, Mirch MC, Ghorbani S, Ranzenhofer LM, Haaga D, Yanovski JA: Binge eating in overweight treatment-seeking adolescents. J Pediatr Psychol 2007; 32:95–105
9.
Garfinkel PE, Lin E, Goering P, Spegg C, Goldbloom DS, Kennedy S, Kaplan AS, Woodside DB: Bulimia nervosa in a Canadian community sample: prevalence and comparison of subgroups. Am J Psychiatry 1995; 152:1052–1058
10.
Cachelin FM, Striegel-Moore RH, Elder KA, Pike KM, Wilfley DE, Fairburn CG: Natural course of a community sample of women with binge eating disorder. Int J Eat Disord 1999; 25:45–54
11.
Fairburn CG, Cooper Z, Doll HA, Norman P, O’Connor M: The natural course of bulimia nervosa and binge eating disorder in young women. Arch Gen Psychiatry 2000; 57:659–665
12.
Morton R: Phthisiologia: Or, a Treatise of Consumptions. London, Smith & Walford, 1694
13.
Gull W: Anorexia nervosa (apepsia hysterica, anorexia hysterica). Transactions of the Clinical Society of London. 1874; 7:222–228
14.
Russell GF, Szmukler GI, Dare C, Eisler I: An evaluation of family therapy in anorexia nervosa and bulimia nervosa. Arch Gen Psychiatry 1987; 44:1047–1056
15.
Robin AL, Siegel PT, Moye AW, Gilroy M, Dennis AB, Sikand A: A controlled comparison of family versus individual therapy for adolescents with anorexia nervosa. J Am Acad Child Adolesc Psychiatry 1999; 38:1482–1489
16.
Mitchell JE, Agras S, Wonderlich S: Treatment of bulimia nervosa: where are we and where are we going? Int J Eat Disord 2007; 40:95–101
17.
Mitchell JE, Agras S, Crow S, Halmi K, Fairburn CG, Bryson S, Kraemer H: Stepped care and cognitive-behavioural therapy for bulimia nervosa: randomised trial. Br J Psychiatry 2011; 198:391–397
18.
Schmidt U, Lee S, Beecham J, Perkins S, Treasure J, Yi I, Winn S, Robinson P, Murphy R, Keville S, Johnson-Sabine E, Jenkins M, Frost S, Dodge L, Berelowitz M, Eisler I: A randomized controlled trial of family therapy and cognitive behavior therapy guided self-care for adolescents with bulimia nervosa and related disorders. Am J Psychiatry 2007; 164:591–598
19.
le Grange D, Crosby RD, Rathouz PJ, Leventhal BL: A randomized controlled comparison of family-based treatment and supportive psychotherapy for adolescent bulimia nervosa. Arch Gen Psychiatry 2007; 64:1049–1056
20.
Tanofsky-Kraff M, Wilfley DE, Young JF, Mufson L, Yanovski SZ, Glasofer DR, Salaita CG: Preventing excessive weight gain in adolescents: interpersonal psychotherapy for binge eating. Obesity 2007; 15:1345–1355
21.
Tanofsky-Kraff M, Wilfley DE, Young JF, Mufson L, Yanovski SZ, Glasofer DR, Salaita CG, Schvey NA: A pilot study of interpersonal psychotherapy for preventing excess weight gain in adolescent girls at-risk for obesity. Int J Eat Disord 2010; 43:701–706
22.
Jones M, Luce KH, Osborne MI, Taylor K, Cunning D, Doyle AC, Wilfley DE, Taylor CB: Randomized, controlled trial of an internet-facilitated intervention for reducing binge eating and overweight in adolescents. Pediatrics 2008; 121:453–462
23.
Safer D, Couturier J, Lock J: Dialectical Behavior Therapy modified for adolescent binge eating disorders: a case report. Cognit Behav Pract 2007; 14:157–167
24.
Arnold LM, McElroy SL, Hudson JI, Welge JA, Bennett AJ, Keck PE: A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder. J Clin Psychiatry 2002; 63:1028–1033
25.
Carter JC, Fairburn CG: Cognitive-behavioral self-help for binge eating disorder: a controlled effectiveness study. J Consult Clin Psychol 1998; 66:616–623
26.
McElroy SL, Arnold LM, Shapira NA, Keck PE Jr, Rosenthal NR, Karim MR, Kamin M, Hudson JI: Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry 2003; 160:255–261
27.
Peterson CB, Mitchell JE, Crow SJ, Crosby RD, Wonderlich SA: The efficacy of self-help group treatment and therapist-led group treatment for binge eating disorder. Am J Psychiatry 2009; 166:1347–1354
28.
Safer DL, Robinson AH, Jo B: Outcome from a randomized controlled trial of group therapy for binge eating disorder: comparing dialectical behavior therapy adapted for binge eating to an active comparison group therapy. Behav Ther 2010; 41:106–120
29.
Wilfley DE, Welch RR, Stein RI, Spurrell EB, Cohen LR, Saelens BE, Dounchis JZ, Frank MA, Wiseman CV, Matt GE: A randomized comparison of group cognitive-behavioral therapy and group interpersonal psychotherapy for the treatment of overweight individuals with binge-eating disorder. Arch Gen Psychiatry 2002; 59:713–721
30.
Safer DL, Telch CF, Chen EY: Dialectical Behavior Therapy for Binge Eating and Bulimia. New York, Guilford Press, 2009
31.
Lock J: The Oxford Handbook of Child and Adolescent Eating Disorders: Developmental Perspectives. New York, Oxford University Press, 2012
32.
Nicholls D, Chater R, Lask B: Children into DSM don’t go: a comparison of classification systems for eating disorders in childhood and early adolescence. Int J Eat Disord 2000; 28:317–324
33.
Hebebrand J, Casper R, Treasure J, Schweiger U: The need to revise the diagnostic criteria for anorexia nervosa. J Neural Transm 2004; 111:827–840
34.
Hebebrand J, Himmelmann GW, Heseker H, Schafer H, Remschmidt H: Use of percentiles for the body mass index in anorexia nervosa: diagnostic, epidemiological, and therapeutic considerations. Int J Eat Disord 1996; 19:359–369
35.
Le Grange D, Doyle PM, Swanson SA, Ludwig K, Glunz C, Kreipe RE: Calculation of expected body weight in adolescents with eating disorders. Pediatrics 2012; 129:e438–e446
36.
Bryant-Waugh R, Nicholls D: Diagnosis and classification of disordered eating in childhood, in Eating Disorders in Children and Adolescents: A Clinical Handbook. Edited by Le Grange D, Lock J. New York, Guilford Press, 2011
37.
Workgroup for Classification of Eating Disorders in Children and Adolescents (WCEDCA), Bravender T, Bryant-Waugh R, Herzog D, Katzman D, Kreipe RD, Lask B, Le Grange D, Lock J, Loeb K, Madden S, Nicholls D, O’Toole J, Pinhas L, Rome E, Sokol-Burger M, Wallen U, Zucker N: Classification of child and adolescent eating disturbances. Int J Eat Disord 2007; 40:S117–S122
38.
Couturier J, Lock J: What is remission in adolescent anorexia nervosa? A review of various conceptualizations and quantitative analysis. Int J Eat Disord 2006; 39:175–183
39.
Couturier J, Lock J, Forsberg S, Vanderheyden D, Yen HL: The addition of a parent and clinician component to the eating disorder examination for children and adolescents. Int J Eat Disord 2007; 40:472–475
40.
Bryant-Waugh R, Kreipe RE: Avoidant/Restrictive Food Intake Disorder in DSM-V. Psychiatr Ann 2012; 42:402–405
41.
Turner H, Bryant-Waugh R: Eating disorder not otherwise specified (EDNOS) profiles of clients presenting at a community eating disorder service. Eur Eat Disord Rev 2004; 12:18–26
42.
Eddy KT, Dorer DJ, Franko DL, Tahilani K, Thompson-Brenner H, Herzog DB: Diagnostic crossover in anorexia nervosa and bulimia nervosa: implications for DSM-V. Am J Psychiatry 2008; 165:245–250
43.
Eisler I, Dare C, Hodes M, Russell G, Dodge E, Le Grange D: Family therapy for adolescent anorexia nervosa: the results of a controlled comparison of two family interventions. J Child Psychol Psychiatry 2000; 41:727–736
44.
Lock J, Agras WS, Bryson S, Kraemer HC: A comparison of short- and long-term family therapy for adolescent anorexia nervosa. J Am Acad Child Adolesc Psychiatry 2005; 44:632–639
45.
Le Grange D: Family therapy outcome in adolescent anorexia nervosa. S Afr J Psychol 1993; 23:174–179
46.
Crisp AH, Norton K, Gowers S, Halek C, Bowyer C, Yeldham D, Levett G, Bhat A: A controlled study of the effect of therapies aimed at adolescent and family psychopathology in anorexia nervosa. Br J Psychiatry 1991; 159:325–333
47.
Gowers SG, Clark A, Roberts C, Griffiths A, Edwards V, Bryan C, Smethurst N, Byford S, Barrett B: Clinical effectiveness of treatments for anorexia nervosa in adolescents: randomised controlled trial. Br J Psychiatry 2007; 191:427–435
48.
Lock J, Le Grange D, Agras WS, Moye A, Bryson SW, Jo B: Randomized clinical trial comparing family-based treatment with adolescent-focused individual therapy for adolescents with anorexia nervosa. Arch Gen Psychiatry 2010; 67:1025–1032
49.
Geist R, Heinmaa M, Stephens D, Davis R, Katzman DK: Comparison of family therapy and family group psychoeducation in adolescents with anorexia nervosa. Can J Psychiatry 2000; 45:173–178
50.
Godart N, Berthoz S, Curt F, Perdereau F, Rein Z, Wallier J, Horreard AS, Kaganski I, Lucet R, Atger F, Corcos M, Fermanian J, Falissard B, Flament M, Eisler I, Jeammet P: A randomized controlled trial of adjunctive family therapy and treatment as usual following inpatient treatment for anorexia nervosa adolescents. PLoS ONE 2012; 7:e28249
51.
Keel PK, Haedt A: Evidence-based psychosocial treatments for eating problems and eating disorders. J Clin Child Adolesc Psychol 2008; 37:39–61
52.
Klerman G, Weissman MM, Rounsaville R, Chevron E: Interpersonal Psychotherapy for Depression. New York, Basic Books, 1984
53.
Dare C, Eisler I: Family therapy for anorexia nervosa, in The Nature and Management of Feeding Problems in Young People. Edited by Cooper I, Stein A. New York, Harwood Academics, 1992, pp 146–160
54.
Lock J, Le Grange D, Agras WS, Dare C: Treatment manual for anorexia nervosa: A family-based approach. New York, Guilford Publications, Inc., 2001
55.
Lock J, Le Grange D: Treatment Manual for Anorexia Nervos: A Family-Based Approach, 2nd ed. New York, Guilford Press, 2013
56.
Bruch H: Eating Disorders: Obesity, Anorexia Nervosa, and the Person Within. New York, Basic Books, 1973
57.
Crisp AH: Anorexia Nervosa as flight from growth: Assessment and treatment based on the model, in Handbook of treatment for eating disorders. Edited by Garner DM, Garfinkel P. New York, Guilford, 1997, pp 248–277
58.
Le Grange D, Eisler I, Dare C, Russell G: Evaluation of family treatments in adolescent anorexia nervosa: a pilot study. Int J Eat Disord 1992; 12:347–357
59.
Couturier J, Kimber M, Szatmari P: Efficacy of family-based treatment for adolescents with eating disorders: a systematic review and meta-analysis. Int J Eat Disord 2013; 46:3–11
60.
Doyle PM, Le Grange D, Loeb K, Doyle AC, Crosby RD: Early response to family-based treatment for adolescent anorexia nervosa. Int J Eat Disord 2010; 43:659–662
61.
Wallis A, Rhodes P, Kohn M, Madden S: Five-years of family based treatment for anorexia nervosa: the Maudsley Model at the Children’s Hospital at Westmead. Int J Adolesc Med Health 2007; 19:277–283
62.
Lock J, Couturier J, Agras WS: Costs of remission and recovery using family therapy for adolescent anorexia nervosa: a descriptive report. Eat Disord 2008; 16:322–330
63.
Dalle Grave R, Calugi S, Doll HA, Fairburn CG: Enhanced cognitive behaviour therapy for adolescents with anorexia nervosa: an alternative to family therapy? Behav Res Ther 2013; 51:R9–R12
64.
Rieger E, Van Buren DJ, Bishop M, Tanofsky-Kraff M, Welch R, Wilfley DE: An eating disorder-specific model of interpersonal psychotherapy (IPT-ED): causal pathways and treatment implications. Clin Psychol Rev 2010; 30:400–410
65.
Federici A, Wisniewski L, Ben-Porath D: Description of an intensive dialectical behavior therapy program for multidiagnostic clients with eating disorders. J Couns Dev 2012; 90:330–338
66.
Pote H, Stratton P, Cottrell D, Boston P, Shapiro D: Systemic family therapy manual. University of Leeds: The Family Therapy Research Center; 2001 http://www.psyc.leeds.ac.uk/research/lftrc/intro_mtap.htm
67.
Kraemer HC, Frank E, Kupfer DJ: Moderators of treatment outcomes: clinical, research, and policy importance. JAMA 2006; 296:1286–1289
68.
Kraemer HC, Kiernan M, Essex M, Kupfer DJ: How and why criteria defining moderators and mediators differ between the Baron & Kenny and MacArthur approaches. Health Psychol 2008; 27(Suppl):S101–S108
69.
Le Grange D, Lock J, Agras WS, Moye A, Bryson SW, Jo B, Kraemer HC: Moderators and mediators of remission in family-based treatment and adolescent focused therapy for anorexia nervosa. Behav Res Ther 2012; 50:85–92
70.
Golden NH, Katzman DK, Kreipe RE, Stevens SL, Sawyer SM, Rees J, Nicholls D, Rome ESSociety For Adolescent Medicine: Eating disorders in adolescents: position paper of the Society for Adolescent Medicine. J Adolesc Health 2003; 33:496–503
71.
Baran SA, Weltzin TE, Kaye WH: Low discharge weight and outcome in anorexia nervosa. Am J Psychiatry 1995; 152:1070–1072
72.
Byford S, Barrett B, Roberts C, Clark A, Edwards V, Smethurst N, Gowers SG: Economic evaluation of a randomised controlled trial for anorexia nervosa in adolescents. Br J Psychiatry 2007; 191:436–440
73.
Le Grange D, Crosby RD, Lock J: Predictors and moderators of outcome in family-based treatment for adolescent bulimia nervosa. J Am Acad Child Adolesc Psychiatry 2008; 47:464–470
74.
Loeb KL, Walsh BT, Lock J, Le Grange D, Jones J, Marcus S, Weaver J, Dobrow I: Open trial of family-based treatment for full and partial adolescent anorexia nervosa in adolescence: evidence of successful dissemination. J Am Acad Child Adolesc Psychiatry 2007; 46:792–800
75.
Le Grange D, Binford R, Loeb KL: Manualized family-based treatment for anorexia nervosa: a case series. J Am Acad Child Adolesc Psychiatry 2005; 44:41–46
76.
Couturier J, Isserlin L, Lock J: Family-based treatment for adolescents with anorexia nervosa: a dissemination study. Eat Disord 2010; 18:199–209
77.
Turkiewicz G, Pinzon V, Lock J, Fleitlich-Bilyk B: Feasibility, acceptability, and effectiveness of family-based treatment for adolescent anorexia nervosa: an observational study conducted in Brazil. Rev Bras Psiquiatr 2010; 32:169–172
78.
Hughes EK, Le Grange D, Court A, Yeo M, Whitelaw M, Atkins L, Sawyer SM: Implementation of family-based treatment for adolescents with anorexia nervosa. J Pediatr Health Care 2014; 28:322–330
79.
Couturier J, Kimber M, Jack S, Niccols A, Van Blyderveen S, McVey G: Understanding the uptake of family-based treatment for adolescents with anorexia nervosa: therapist perspectives. Int J Eat Disord 2013; 46:177–188
80.
Crow SJ, Mitchell JE, Roerig JD, Steffen K: What potential role is there for medication treatment in anorexia nervosa? Int J Eat Disord 2009; 42:1–8
81.
Walsh BT, Kaplan AS, Attia E, Olmsted M, Parides M, Carter JC, Pike KM, Devlin MJ, Woodside B, Roberto CA, Rockert W: Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial. JAMA 2006; 295:2605–2612
82.
Beato Fernández L, Rodríguez Cano T: Uso de antipsicóticos en el tratamiento de pacientes con trastorno de la conducta alimentaria: estudio con risperidona. (in Spanish). [Antipsychotics in treatment of eating disorders patient: a study with risperidone]. Actas Esp Psiquiatr 2005; 33:33–40
83.
Hagman J, Gralla J, Sigel E, Ellert S, Dodge M, Gardner R, O’Lonergan T, Frank G, Wamboldt MZ: A double-blind, placebo-controlled study of risperidone for the treatment of adolescents and young adults with anorexia nervosa: a pilot study. J Am Acad Child Adolesc Psychiatry 2011; 50:915–924
84.
Lock J: Adjusting cognitive behavior therapy for adolescents with bulimia nervosa: results of case series. Am J Psychother 2005; 59:267–281
85.
Kaye WH, Fudge JL, Paulus M: New insights into symptoms and neurocircuit function of anorexia nervosa. Nat Rev Neurosci 2009; 10:573–584
86.
Marsh R, Horga G, Wang Z, Wang P, Klahr WK, Berner LA, Walsh BT, Peterson BS: An FMRI study of self-regulatory control and conflict resolution in adolescents with bulimia nervosa. Am J Psychiatry. 2011; 168:1210–1633
87.
Garrett A, Datta N, Fitzpatrick K, Lock J: Brain activation associated with set-shifting and central coherence skills in patients with anorexia nervosa (poster). Montreal, Canada, International Academy of Eating Disorders, 2013
88.
Wagner DD, Boswell RG, Kelley WM, Heatherton TF: Inducing negative affect increases the reward value of appetizing foods in dieters. J Cogn Neurosci 2012; 24:1625–1633
89.
Wagner A, Aizenstein H, Venkatraman VK, Fudge J, May JC, Mazurkewicz L, Frank GK, Bailer UF, Fischer L, Nguyen V, Carter C, Putnam K, Kaye WH: Altered reward processing in women recovered from anorexia nervosa. Am J Psychiatry 2007; 164:1842–1849
90.
Bohon C, Stice E: Reward abnormalities among women with full and subthreshold bulimia nervosa: A functional magnetic resonance imaging study. Int J Eat Disord, 2011; 44:585–595
91.
Treasure J: Getting beneath the phenotype of anorexia nervosa: the search for viable endophenotypes and genotypes. La revuew de psychiatrie. 2007; 52:212–219
92.
Tchanturia K, Lloyd S, Lang K: Cognitive remediation therapy for anorexia nervosa: current evidence and future research directions. Int J Eat Disord 2013; 46:492–495
93.
Tchanturia K, Davies H, Roberts M, Harrison A, Nakazato M, Schmidt U, Treasure J, Morris R: Poor cognitive flexibility in eating disorders: examining the evidence using the Wisconsin Card Sorting Task. PLoS ONE 2012; 7:e28331
94.
Fonville L, Lao-Kaim NP, Giampietro V, Van den Eynde F, Davies H, Lounes N, Andrew C, Dalton J, Simmons A, Williams SC, Baron-Cohen S, Tchanturia K: Evaluation of enhanced attention to local detail in anorexia nervosa using the embedded figures test; an FMRI study. PLoS ONE 2013; 8:e63964
95.
Fitzpatrick K, Lock J, Darcy A, Colburn D, Gudorf C (ed): Neuorcognitive processes in adolescent anorexia nervosa. Honolulu, HI, American Academy of Child and Adolescent Psychiatry, 2009
96.
Wykes T, Reader C: Cognitive remediation therapy for schizophrenia: an introduction. London, UK, Brunner Routledge, 2005
97.
Lindenmayer JP, McGurk SR, Mueser KT, Khan A, Wance D, Hoffman L, Wolfe R, Xie H: A randomized controlled trial of cognitive remediation among inpatients with persistent mental illness. Psychiatr Serv 2008; 59:241–247
98.
Buhlmann U, Deckersbach T, Engelhard I, Cook LM, Rauch SL, Kathmann N, Wilhelm S, Savage CR: Cognitive retraining for organizational impairment in obsessive-compulsive disorder. Psychiatry Res 2006; 144:109–116
99.
Lock J, Agras WS, Fitzpatrick K, Jo B, Bryson S, Tchanturia K: Addressing treatment dropout in anorexia nervosa using cognitive remediation therapy. Int J Eat Disord 2013; 46:567–575
100.
Marsh R, Steinglass JE, Gerber AJ, Graziano O’Leary K, Wang Z, Murphy D, Walsh BT, Peterson BS: Deficient activity in the neural systems that mediate self-regulatory control in bulimia nervosa. Arch Gen Psychiatry 2009; 66:51–63
101.
Steiger H, Bruce K: Phenotypes, endophenotypes and genotypes in bulimia spectrum eating disorders. La revue canadienne de psychiattrie. 2007; 52:220–227.
102.
Whiteside U, Chen E, Neighbors C, Hunter D, Lo T, Larimer M: Difficulties regulating emotions: Do binge eaters have fewer strategies to modulate and tolerate negative affect? Eat Behav 2007; 8:162–169
103.
Steiger H, Gauvin L, Israël M, Koerner N, Ng Ying Kin NM, Paris J, Young SN: Association of serotonin and cortisol indices with childhood abuse in bulimia nervosa. Arch Gen Psychiatry 2001; 58:837–843
104.
Barry L, De Feo D: Emotion and eating psychopathology: links with attitudes toward emotional expression among young women. Int J Eat Disord 2010; 2:187–189
105.
Chen EY, Matthews L, Allen C, Kuo JR, Linehan MM: Dialectical behavior therapy for clients with binge-eating disorder or bulimia nervosa and borderline personality disorder. Int J Eat Disord 2008; 41:505–512
106.
Telch CF, Agras WS, Linehan MM: Group dialectical behavior therapy for binge-eating disorder: a preliminary controlled trial. Behav Ther 2000; 31:569–582

Information & Authors

Information

Published In

History

Published online: 1 January 2014
Published in print: Fall 2014

Authors

Details

James Lock, M.D., Ph.D.

Notes

Address correspondence to: James Lock, M.D., Ph.D., Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Stanford, CA 94305; e-mail: [email protected]

Funding Information

Author Information and CME Disclosure
James Lock, M.D., Ph.D., Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA
Dr. Lock receives royalties from books published by Guilford Press and Oxford University Press. He also received payments for training from the Training Institute for Child and Adolescent Eating Disorders. He serves on the scientific advisory boards of the National Eating Disorder Association, the Global Foundation for Eating Disorders, and Centers for Discovery. He has received grants over the past 5 years from the National Institute of Mental Health, the Davis Foundation, the Children’s Health Research Institute of the Lucile Packard Foundation, and the Global Foundation for Eating Disorders.
Dr. Lock is currently supported by funds from the Davis Foundation, The Global Foundation for Eating Disorders, and a Mid-Career Award from the National Institute of Mental Health (K24 MH074467).

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Focus

PPV Articles - Focus

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share